Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Revenue

Arrowhead Pharmaceuticals had revenue of $2.50M in the quarter ending December 31, 2024, a decrease of -29.60%. This brings the company's revenue in the last twelve months to $2.50M, down -98.62% year-over-year. In the fiscal year ending September 30, 2024, Arrowhead Pharmaceuticals had annual revenue of $3.55M, down -98.52%.

• Revenue (ttm): $2.50M
• Revenue Growth: -98.62%
• P/S Ratio: 566.94
• Revenue / Employee: $4,105
• Employees: 609
• Market Cap: 1.42B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	3.55M	-237.18M	-98.52%
Sep 30, 2023	240.74M	-2.50M	-1.03%
Sep 30, 2022	243.23M	104.94M	75.89%
Sep 30, 2021	138.29M	50.30M	57.16%
Sep 30, 2020	87.99M	-80.80M	-47.87%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.